Ryan is a senior director of business development for the Catalyze360 organization at Eli Lilly. In this role, he negotiates collaboration agreements with biotech partners to enable their science to advance from the lab to the clinic. Ryan started at Lilly in 2017 in Global & US Market Access. He successfully executed many contracts with top PBMs and health insurance plans in the US as well as led price strategy development for new drug launches. Ryan obtained a BSc degree in Nutrition from Brigham Young University and PharmD and MBA degrees from Butler University.